American Association for Cancer Research: Potentially Targetable Fusion RNAs May Be More Common in Metastatic Breast Cancer Than Previously Realized
December 08, 2023
December 08, 2023
SAN ANTONIO, Texas, Dec. 8 (TNSres) -- The American Association for Cancer Research issued the following news release:
Comprehensive profiling of fusion RNAs present in a large cohort of metastatic breast tumors revealed unique fusion mutations that may be therapeutically targetable, according to results presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.
Fusion mutations occur when a portion of one gene becomes fused to a portion of another, . . .
Comprehensive profiling of fusion RNAs present in a large cohort of metastatic breast tumors revealed unique fusion mutations that may be therapeutically targetable, according to results presented at the San Antonio Breast Cancer Symposium, held December 5-9, 2023.
Fusion mutations occur when a portion of one gene becomes fused to a portion of another, . . .